Screener
Hims & Hers Health HIMS EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Hims & Hers Health’s reported figures.
The source filing: Hims & Hers Health’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001773751-26-000076
FAQ
- What is Hims & Hers Health's EBITDA?
- Hims & Hers Health (HIMS) reported EBITDA of -$56.37M in Q1 2026.
- How has Hims & Hers Health's EBITDA changed year-over-year?
- Hims & Hers Health's EBITDA decreased by 185.2% year-over-year, from $66.17M to -$56.37M.
- What is the long-term trend for Hims & Hers Health's EBITDA?
- Over 4 years (2021 to 2025), Hims & Hers Health's EBITDA has grown at a 9.6% compound annual growth rate (CAGR), from -$110.97M to $160.12M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Hims & Hers Health's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude